-
AI Meets Clinical Photography: Inside Michael Golinko’s ImageAssist
Michael Golinko was recognized as Brock Family Center for Applied Innovation’s 2025 Innovator of the Year, where he shared how ImageAssist, Inc. came to life. -
Vanderbilt Center for Technology Transfer and Commercialization
The CTTC transforms intellectual property into industry applications, fosters regional economic development through local licensing, and supports the creation of new ventures. -
Role of Patents in Vanderbilt Research: Insights from CTTC's Lunch and Learn
By navigating existing patents, purchasing licenses, or exploring alternative technologies, faculty researchers can proceed without legal hurdles. -
Vanderbilt CTTC drives record innovation impact in FY25
Vanderbilt CTTC had an exceptional 2025 fiscal year, setting all-time records across multiple metrics while expanding the university's innovation impact. -
Vanderbilt Innovation Ambassadors Program Bridges Gap Between Research and Commercialization
Vanderbilt’s Innovation Ambassadors Program is transforming how academic discoveries translate into societal impact through a peer-to-peer approach that has become a model for universities nationwide. -
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential -
Turning Research into Real-World Impact: CTTC Lunch & Learn Series
Through this series, researchers will gain valuable insights into innovation, intellectual property, commercialization pathways, and the startup landscape—all while balancing their academic careers. See below upcoming events in the series. -
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia. -
Connecting Research to Real-World Solutions: Karl Zelik's HeroWear Journey
Karl Zelik, a Vanderbilt biomechanical engineer, turned academic research into HeroWear, a company making soft exosuits that reduce back strain and injuries for workers. HeroWear has grown into a global solution that improves safety, comfort, and quality of life for thousands, showing the power of…